Search Results - "Konkol, B"

Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series by Konkol, Samuel, Morrisette, Matthew, Hulse, Matthew, Enfield, Kyle, Mihalek, Andrew

“…Catecholamine-resistant postoperative vasoplegic syndrome (PVS) lacks effective treatment modalities. Synthetic angiotensin II was recently approved for the…”
Get full text

Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients by Budnick, Isadore M, Davis, Jessica P E, Sundararaghavan, Anirudh, Konkol, Samuel B, Lau, Chelsea E, Alsobrooks, James P, Stotts, Matthew J, Intagliata, Nicolas M, Lisman, Ton, Northup, Patrick G

“…Fibrinogen (FIB) levels less than 150 mg/dL have been associated with increased rates of bleeding and lower survival in critically ill cirrhosis patients.  We…”
Get more information

Differences in lung function between major race/ethnicity groups following hospitalization with COVID-19 by Konkol, Samuel B., Ramani, Chintan, Martin, David N., Harnish-Cruz, Carissa K., Mietla, Kelsie M., Sessums, Ryan F., Widere, John C., Kadl, Alexandra

“…Ethnic minorities have higher rates of infection, hospitalization, and death from COVID-19 compared to White Americans. Is race/ethnicity an independent…”
Get full text

The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif by LEWITZKY, Marc, KARDINAL, Christian, GEHRING, Niels H, SCHMIDT, Enrico K, KONKOL, Birgit, EULITZ, Manfred, BIRCHMEIER, Walter, SCHAEPER, Ute, FELLER, Stephan M

“…The adapter Grb2 is an important mediator of normal cell proliferation and oncogenic signal transduction events. It consists of a central SH2 domain flanked by…”
Get full text

Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SoS complexes by Kardinal, Christian, Konkol, Birgit, Lin, Hui, Eulitz, Manfred, Schmidt, Enrico K., Estrov, Zeev, Talpaz, Moshe, Arlinghaus, Ralph B., Feller, Stephan M.

“…Chronic myelogenous leukemia (CML) is commonly characterized by the presence of the p210Bcr-Abl oncoprotein. Many downstream effectors of Bcr-Abl have been…”
Get full text

Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients by Kardinal, C, Konkol, B, Schulz, A, Posern, G, Lin, H, Adermann, K, Eulitz, M, Estrov, Z, Talpaz, M, Arlinghaus, R B, Feller, S M

“…Bcr-Abl contributes prominently to the development of most chronic myeloid leukemias (CMLs). Prior work has identified the adapter protein CRKL as a major…”
Get full text

Cell‐penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients by Kardinal, Christian, Konkol, Birgit, Schulz, Axel, Posern, Guido, Lin, Hui, Adermann, Knut, Eulitz, Manfred, Estrov, Zeev, Talpaz, Moshe, Arlinghaus, Ralph B., Feller, Stephan M.

Get full text